Company News, New Products

BeautyHealth’s SkinStylus Receives New FDA Clearance for Facial Acne Scarring

Categorized by the FDA as a Class II medical device, it is approved for facial acne scarring in Fitzpatrick skin types I, II and III.

Author Image

By: Lianna Albrizio

Associate Editor

The US Food and Drug Administration (FDA) has cleared Beauty Health Company’s SkinStylus microneedling device for use on facial acne scarring in Fitzpatrick skin types I, II and III in patients aged 22 years and older, making it the only microneedling device FDA cleared for both the face and abdomen, according to the company.   The clearance from the FDA is a notable milestone for SkinStylus since its acquisition by BeautyHealth in February of this year. “SkinStylus’ new facial in...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters